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Background: The electrocardiogram or ECG has been in use for over
100 years and remains the most widely performed diagnostic test for charac-
terization of cardiac structure and electrical activity. Remarkably, current ap-
proaches to automated ECG interpretation originate from heuristics devised
over 40 years ago. textbfObjective: We hypothesized that parallel advances
in computing power, innovations in machine learning algorithms, and avail-
ability of large-scale digitized ECG data would enable extending the utility
of the ECG beyond its current limitations, while at the same time preserv-
ing interpretability, an attribute which remains critical to medical decision-
making. Methods: We identified 36,186 ECGs from the UCSF database
that were 1) in normal sinus rhythm and 2) would enable training of specific
models for estimation of cardiac structure or function or detection of disease.
We derived a novel model for ECG segmentation using convolutional neu-
ral networks (CNN) and Hidden Markov Models (HMM) and evaluated its
output by comparing electrical interval estimates to 141,864 measurements
produced during the clinical workflow. We built a 725-element patient-level
ECG profile using downsampled ECG segmentation data and trained ma-
chine learning models to estimate left ventricular mass, left atrial volume,
mitral annulus e’ and to detect and track four diseases: pulmonary arterial
hypertension (PAH), hypertrophic cardiomyopathy (HCM), cardiac amyloid
(CA), and mitral valve prolapse (MVP). Results: CNN-HMM derived ECG
segmentation agreed with clinical estimates, with median absolute deviations
(MAD) as a fraction of observed value of 0.6% for heart rate, 3% for PR in-
terval, 4% for QT interval, and 6% for QRS duration. Patient-level ECG
profiles enabled quantitative estimates of left ventricular mass (MAD vs.
echocardiogram of 16%) and mitral annulus e’ velocity (MAD of 19%) with
good discrimination in binary classification models of left ventricular hyper-
trophy and diastolic dysfunction [Area Under the Receiver Operating Char-
acteristic Curve (AUROC) of 0.87 and 0.84, respectively]. Models for dis-
ease detection ranged from AUROC of 0.94 for PAH, 0.91 for HCM, 0.86 for
CA, and 0.77 for MVP. Top-ranked variables for all models included known
ECG characteristics along with novel predictors of these traits/diseases. Fur-
thermore, temporal variation in model-derived disease scores coincided with
visual evolution of ECG morphologies for these features. Conclusion: Mod-
ern AI methods can extend the 12-lead ECG to quantitative and diagnostic
applications well beyond its current uses. Moreover, careful selection of
machine learning algorithms achieves the goal of automation and accuracy
without compromising the transparency that is so fundamental to clinical
care and scientific discovery.
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Introduction
The electrocardiogram (ECG) is the most commonly per-
formed cardiovascular diagnostic procedure, with more than
100 million ECGs obtained annually in the United States (1),
including use in 21% of annual health examinations (2) and
17% of emergency department visits (3). The ECG tracing
is a direct reflection of underlying cardiac physiology, since
its morphologic and temporal features are produced from
cardiac electrical and structural variations. The paradigm
of ECG interpretation has remained largely unchanged for
decades: both physicians and computer algorithms apply spe-
cific rules — initially established by empiric, manual analysis
and codified by clinical guidelines — to interrogate the ECG
tracing for evidence of underlying disease (4).
Although modern ECG interpretation emphasizes bi-
nary classification (e.g. left ventricular hypertrophy or not),
given the multiple physiologic and structural correlates of
ECG signals, ECGs could be trained to estimate continu-
ous parameters (i.e. a regression model), including struc-
tural and functional attributes of the heart. Moreover, for
both classification and regression tasks, modern algorithms
should also identify which components of the ECG signal
drive their performance. Such an approach would provide
the foundation not only to enable the discovery of new asso-
ciations between the ECG signal and disease pathology, but
also provide the transparency needed to reassure physicians
and patients about the basis and validity of any automated
diagnosis or parameter estimate.
Since their introduction over 40 years ago (5), comput-
erized algorithms have assisted physicians in ECG interpre-
tation and are largely based upon the same expert-designed
rules used by physicians. These rules have themselves been
largely unchanged for decades, and derive from empiric,
manual analysis of ECGs from various disease cohorts (6).
Analysis performed in this way can only evaluate simple
heuristics on a small subset of the total information contained
in an ECG, and has led to the familiar menu of criteria by
which ECGs are evaluated, such as an R-wave >12mm in
lead aVL suggesting left ventricular hypertrophy, according
to the modified Cornell criteria (7). This traditional approach
to ECG analysis does not readily account for high-level inter-
actions between ECG signals from multiple leads, or small
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visually imperceptible yet informative changes which may
exist in the signal, particularly in early disease stages.
Novel techniques to analyze digital ECG data at large-
scale would be foundational toward the goals of both im-
proving algorithmic ECG interpretation and identifying novel
ECG correlates of cardiac disease beyond existing criteria,
all within a low-cost structure. A physician’s ability to track
disease could also be substantially augmented by the abil-
ity to monitor and integrate subtle changes in serial ECGs.
Presently, there does not exist an automated, scalable, algo-
rithmic method to perform detailed longitudinal tracking and
comparison of ECGs.
Machine learning algorithms have recently demon-
strated revolutionary performance in the fields of computer
vision (8) and speech recognition (9), and more recently in
medical applications (10, 11), but many of these innovative
models suffer from being largely uninterpretable (12). In
high-stakes fields such as medicine, this limits the ability
to understand successes or troubleshoot failures, potentially
dampening physician adoption of an unfamiliar technology.
We aimed to develop and test an algorithmic framework
that facilitates scalable analysis of ECG data, while preserv-
ing interpretable parallels to cardiac physiology. This ap-
proach aspires to expand the flexibility and scalability of al-
gorithmic ECG analysis, laying the crucial foundation to per-
form a wide range of novel ECG-based tasks including im-
proving accuracy, estimating quantitative cardiac traits, per-
forming longitudinal tracking of serial ECGs, and monitoring
disease progression and risk.
Materials and Methods
The source code for this project, including model weights, is
available at https://bitbucket.org/rahuldeo/ecgai/.
A. Human Subjects Research. University of California,
San Francisco (UCSF) institutional review board approval
was obtained for this study.
B. Overview: Automated and interpretable ECG pro-
filing for disease detection, tracking and discovery.
We sought to develop an automated, scalable, and inter-
pretable method to characterize 1) cardiac structure and 2) di-
astolic function; and 3) detect and track disease using patient-
specific ECG profiles. Figure 1 demonstrates the analysis
pipeline, data inputs and number of ECGs that were used
in each step of algorithm development and validation. We
termed the entire approach as ecgAI - referring to "artificial
intelligence".
C. ECG Data. Standard 12-lead ECG data from 2010-2017
was obtained in XML format from the University of Cali-
fornia, San Francisco (UCSF) clinical MUSE ECG database
(MUSE Version 9.0 SP4, GE Healthcare, Wauwatosa, WI).
Based on accompanying clinical and echocardiographic
(echo) information (described below) we selected 36,186
ECGs, from which raw ECG voltage data was extracted for
each of the 12 individual leads recorded over 10 seconds;
60% of data was sampled at a frequency of 500Hz, and 40%
was sampled at 250Hz. As part of routine clinical care, each
clinical ECG undergoes initial analysis by the GE software
(MAC 5500 HD, Version 10, Revision F; Marquette 12SL;
GE Healthcare, Wauwatosa, WI), and the interpretation is
subsequently changed or confirmed by a UCSF cardiolo-
gist. We extracted standard ECG GE MUSE measurements,
as well as final cardiologist-confirmed ECG diagnostic in-
terpretations. Data from the UCSF electronic health record
was obtained for relevant patients, including medical diag-
noses, medications, specialty clinic referrals, and echo mea-
surements.
D. Selection of studies for model development. We se-
lected a subset of ECGs to train models for estimation of
cardiac structure and function and detection of disease. To
facilitate model development, we restricted the analyses to
those ECGs for which the GE/UCSF rhythm interpretation
was normal sinus rhythm.
For cardiac structure models, we searched the UCSF
echo database for all instances of patients with echos and
ECGs collected within 30 days of one another and who had
recorded measurements either of left ventricular mass or left
atrial volume. We found 10082 (Table S1) and 8289 (Table
S2) studies, respectively, that met these criteria. For cardiac
diastolic function, we performed a similar search and found
4205 instances of patients with an ECG and a recorded mitral
annulus medial e’ value on echo within 30 days of each other
(Table S3). There were fewer instances of lateral e’ values
recorded within our database and we thus focused our efforts
on the medial e’ metric.
We selected four diseases for which to perform a clinical
demonstration of automated detection and tracking of disease
using patient ECG profiles: pulmonary arterial hypertension
(PAH), hypertrophic cardiomyopathy (HCM), cardiac amy-
loidosis (CA) and mitral valve prolapse (MVP). We previ-
ously identified the PAH, HCM and CA patients as part of a
parallel study on developing a computer vision pipeline for
automated echo interpretation (13). Briefly, on chart review
HCM patients met guideline-based criteria (14); CA patients
had both echo evidence of hypertrophy and confirmation of
amyloidosis by biopsy or imaging; and PAH patients had an
echo-indication of PAH and were on one of four PAH spe-
cific medications. MVP patients were identified by querying
the UCSF echo database for patients with single or bileaflet
MVP. Echo studies were subsequently over-read by a sec-
ond board-certified cardiologist to confirm the diagnosis. We
selected all ECGs corresponding to these patients that were
available in XML format. To build classification models, we
also matched each ECG to up to five ECGs matched by age
(in 10 years bins), sex, year of study and race (the patient de-
mographic information for ECGs in our archive has been or-
ganized in a python dictionary to facilitate the control selec-
tion process). Patient and study characteristics are described
in Tables S4, S5, S6, and S7.
E. ecgAI: a machine learning based approach to ECG
segmentation. To develop novel models to extend the util-
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ity of ECGs, we needed an efficient way to derive patient-
specific ECG profiles, vectors of uniform length that capture
the variation in ECG voltage over different leads. This first
required a method to segment ECGs into their different com-
ponents.
Historically, ECG segmentation has involved the appli-
cation of a discrete or continuous wavelet transform to the
raw ECG signal to help identify peaks (15). Typically, the
QRS complex is located first, and then heuristics are applied
(e.g. march backwards no more than a certain number of mil-
liseconds until the signal diminishes below a certain thresh-
old) to determine the onset of the QRS and the onset and ter-
mination of the P and T waves. Additional heuristics can be
introduced to deal with abnormal heart rhythms such as atrial
fibrillation or premature beats as well as difficult to detect
P-waves and abnormally shaped QRS complexes.
Although effective, such heuristic-based approaches
tend to be challenging to develop, as one must enumerate the
exceptions to this initial approach and devise new rules to
accommodate them. In this work, we explored the develop-
ment of an alternative, technically novel approach to train an
ECG segmentation model, capitalizing on recent advances in
machine learning in the fields of computer vision and signal
processing.
E.1. Convolutional Neural Networks for ECG segmentation.
Building on our initial success in segmenting echos (13), we
trained a convolutional neural network (CNN)-based model
to delineate individual segments within the ECG. Convolu-
tional neural networks and the broader approach of "deep
learning" have revolutionalized the field of computer vision
(16). Deep learning involves training a multilayer model,
where each layer achieves an expanded representation of the
layer below it. The lowest level takes in raw data and learn
how to perform an initial level of abstraction, such as rec-
ognizing edges in an image. Each subsequent layer takes as
input the layer below it and builds ever more complex ab-
stractions. The top layer can then be used for a classification
task, such as recognizing the subject of an image or localizing
objects within it (i.e. segmentation). Unlike heuristic-based
approaches, CNN models do not require user-specified rules
but instead rely on abundant amounts of labeled input data.
They then learn the rules needed to perform the desired task.
As training data, we downloaded raw ECG voltage data
from two sources: 112 ECGs from the PTB Diagnostic
database (17) and 58 ECGs from the UCSF database. For
each ECG, we extracted a two-second strip and manually as-
signed to each one millisecond block one of six possible la-
bels: P wave, PR segment (termination of P wave to start of
QRS), QRS complex, ST segment, T wave, and TP segment.
We then trained a multilayered neural network to de-
tect these segments within an ECG. The architecture of our
network was based on the U-net network (18) (2 A). Our net-
work accepted a 12 x 2000 input vector and was composed
of sequential contracting and expanding paths with a total of
32 convolutional layers, 5 max pool layers, and 3 deconvo-
lutional layers. The output of this CNN is a vector of ECG
segment classes, identical in length to the input vector. (Sup-
plementary Note 1)
E.2. Enhancing ECG segmentation with Hidden Markov
Models. Although U-Nets can provide accurate segmentation
of objects, they fail to take advantage of the obligate order-
ing of elements in a typical ECG. For example the ST seg-
ment must follow a QRS complex and T waves should follow
the ST segment. We thus trained a second machine learning
model known as a Hidden Markov Model to accept the out-
put of the U-Net and provide improved segmentation. Hidden
Markov models (HMM) consists of four elements (19): 1) an
exhaustive set of different states, which in our case represent
the different of segments of the ECG; 2) baseline probabili-
ties of the states, reflecting the relative duration of the vari-
ous segments; 3) the probability of moving from one state to
another, which is captured in a transition probability matrix;
and 4) an emission probability matrix. The emission proba-
bility matrix describes the probability of seeing a given state
in the input data, conditional on the true underlying state. It
addresses the issue that noisy input data, such as the output
of the U-Net, has many examples where the true state is in-
correctly assigned. The probabilities of these errors are not
uniform - for example noise in the TP segment is sometimes
interpreted as a new P wave, but one is unlikely to confuse
the TP segment with a QRS complex. To train the HMM, we
input baseline and transition probabilities based on our manu-
ally segmented data and allowed the model to learn emission
probabilities from the U-Net output on the training data.
As a final step, we introduced a series of simple heuris-
tic filters to eliminate implausibly short ECG complexes (i.e.
<10 mseconds).
E.3. Validation of ECG segmentation. Validation of segmen-
tation performance was done in two ways. First we computed
the Intersection over Union metric, or IoU, to compare the
model output to manual labels. The IoU takes the number of
pixels which overlap between the ground truth and automated
segmentation (for a given class, such as the QRS complex)
and divides them by the total number of pixels assigned to
that class by either method. It ranges between 0 and 100.
Second, we calculated standard ECG intervals based on
the CNN-segmented ECGs for all ECGs in our sample and
compared these against 141,864 ECG intervals derived from
the GE MUSE software (these were derived from the 35,466
ECGs for which all four intervals were computed by both
methods). Concordance between intervals was assessed us-
ing absolute differences, as a percentage of the reference
(MUSE) value.
F. Deriving patient-level ECG profiles. Because ECG
waveforms and intervals have corollaries to electrical and
structural cardiac physiology, a crucial principle to our ap-
proach aimed to create a representation of the raw ECG
data which preserves these features while still decreasing
the feature space, making it tractable for analysis by inter-
pretable machine learning algorithms. This approach also fa-
cilitates longitudinal tracking of clinically important features
over time. To achieve this, we developed a 725-component
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Fig. 1. Workflow for ecgAI project. An ECG segmentation model was training using 170 manually labeled ECGs. A subset of ECGs were selected from the UCSF
for training interpretable models to estimate cardiac structure and function and detect and track disease. Segmentation of these ECGs enabled computation of standard
physiologic intervals, which were then compared with the output of the MUSE/UCSF reference data. ECGs with good agreement were used to derive a 725-element patient-
level ECG profile vector, which then served as input to train regression and classification models using the gradient boosting algorithm. The primary ECG features underlying
each of these models was examined. Number of ECGs used for the various tasks are indicated in parentheses. For disease detection, a slash separates the number of cases
and control ECGs used. Curved rectangles represent training data; ellipses represent algorithms; and standard rectangles represent other data types. CNN = Convolutional
Neural Network; HMM = Hidden Markov Model; NSR = Normal Sinus Rhythm; HCM = Hypertrophic cardiomyopathy; PAH = Pulmonary arterial hypertension; MVP = Mitral
valve prolapse; LV = left ventricle; LA = left atrium.
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ECG vector representation consisting of the following com-
ponents, all of which were derived from corresponding seg-
ments of the CNN-segmented ECG. The PR interval, P-wave
duration, QRS interval, heart rate, and QT intervals were cal-
culated and averaged across all cardiac cycles and across 12-
leads, and the five averaged values were included as five com-
ponents in the ECG vector. For each of the following seg-
ments, the vector of raw-voltage amplitude from each of the
12 leads was resized to 20 pixels by linear interpolation, av-
eraged across all cardiac cycles, and included as ECG vector
components (totaling 720 components): the PR interval, the
QRS complex and the ST-T-wave complex (including both
the ST segment and the T wave).
This 725-component ECG vector representation was
calculated for each study ECG and input into machine learn-
ing algorithms, as below, for estimation of cardiac structure
and function and for disease detection. Distinct from input-
ing raw ECG voltage data into a neural network (20, 21)
this vectorization process preserves meaningful representa-
tions of features within the ECG, facilitating interpretability.
G. ECG-Derived Estimates of Cardiac structure and
Function. The ECG patient vector was used as an input
to train models to estimate left ventricular mass (indexed
for body surface area, LVMi), left atrial volume (indexed,
LAVOLi) and mitral annular medial e’ (medial e’). Antici-
pating complex interactions among input features, as well as
heterogeneity amongst patients (22), we employed a machine
learning algorithm known as a Gradient Boosted Machine
(23) (GBM), which is an ensemble regression-tree based
technique. In this technique, a large number of decision trees
are fit sequentially, with each successive tree being fit to the
residuals of the prior tree, allowing each tree to become an
expert in a subset of the data. In addition to being among the
most powerful machine learning techniques for both classi-
fication and regression, the relative importance of input pre-
dictors in GBM models can be examined through variable
importance analysis, providing results that are interpretable
with respect to ECG representations of cardiac physiology.
Individual GBM models were trained to estimate the three
continuous structure and function metrics. We also generated
dichotomous measures for each of these, treating controls as
individuals with values below (for LVMi and LAVOLi) or
above (medial e’) the median value, and cases as individu-
als above or below the 10th percentile (Tables S5, S6, and
S7). Given that we noted occasional inaccuracy in both our
CNN-HMM segmentation model as well as in the MUSE val-
ues, we limited our models to ECGs with substantial agree-
ment (mean difference < 10%) across the RR, PR, QRS, and
QT intervals. There was no appreciable difference in patient
characteristics for this subset (Tables S1, S2, and S3). Models
were fit using the GBM function in the R caret package. Tun-
ing parameters were selected in an automated manner using
3-fold cross-validation. Accuracy was assessed using 5-fold
cross validation, with AUROC curves used to evaluate clas-
sification tasks and absolute differences (50th, 75th, and 95th
percentiles) and Bland-Altman plots (24) used for continu-
ous measures. Variable importance was extracted for each of
the 725 features and averaged over cross-validation runs. To
facilitate interpretation, values for voltage variation in ECG
leads were binned so that each segment (e.g. QRS) was rep-
resented by 5 rather than 20 bins.
H. Disease detection and tracking: Training Gradient
Boosted Models to Quantify Diseases. In addition to
quantifying cardiac structure, we also trained GBM models
using similar methods to detect PAH, HCM, CA, and MVP.
Separate GBM models were trained to output a probability
for each disease based on an input ECG vector. To demon-
strate the use of this approach to track longitudinal changes
in disease over time, we selected all patients who had ECGs
in two or more years, and took the median score per patient
for each year. Scores were plotted as a function of year.
I. Statistical Methods. All analyses were performed using
R 3.3.2 or python 2.7. Differences between case and con-
trol characteristics for the diseases detection models were
performed using two-tailed Wilcoxon-Mann-Whitney tests,
t-tests, or chi-square tests. Only a single value was taken
per patient in these pairwise comparisons. The areas under
the receiver operating characteristic curve for disease detec-
tion models were computed with the help of the pROC and
hmeasure packages in R. Confidence intervals were gener-
ated by the method of Delong (25), as implemented in the
pROC package. The only predictor for these models was the
patient-level disease score, as output by the GBM model.
Convolutional neural networks were developed using
the TensorFlow python package (26). Signal manipulation
(such as linear interpolation for resizing) was performed us-
ing scikit-image (27).
Results
J. Validation of ecgAI Machine Learning-based ECG
Segmentation. Our ecgAI algorithmic pipeline (Figures 2A
and 2B) was trained on 170 manually segmented ECGs, and
deployed on 36,186 sinus rhythm ECGs (Figure 1). Exam-
ple output from the ecgAI model is shown in Figure 2C, with
every time-step along the ECG tracing being classified as be-
longing to one of the six segments (illustrated in the Figure
by separate colors).
The IoU metrics for ECG segmentation were 91 (P
wave), 85 (PR segment), 94 (QRS complex), 88 (ST seg-
ment), 91 (T wave), and 92 (TP segment). As a second indi-
rect validation of segmentation performance, standard ECG
interval measurements were calculated based on ecgAI seg-
mentation on 35,466 ECGs not included in the training set
and compared against the reference MUSE values (Table 1).
Overall, intervals calculated from ecgAI-derived segmenta-
tion demonstrated good agreement with MUSE calculated in-
tervals. Median absolute deviation between ecgAI-derived
intervals was <6% when compared to MUSE interpreted in-
tervals, with Heart Rate, PR, QRS and QT intervals exhibit-
ing 0.6%, 3.0%, 5.6% and 4.4% median absolute deviation,
respectively (Table 1). Intervals from ecgAI-measurements
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Fig. 2. ecgAI method of ECG segmentation. A. Architecture of convolutional neural network used for ECG segmentation. Grey rectangles represent layers with dimensions
listed below. The notation for each layer indicates the size of the input (e.g. 2000 ms, initially) by the number of leads (e.g. 12) by the number of filters. The size of the filter
is specified in the body of the rectangle. B. Architecture of HMM used after CNN-based segmentation. Gray boxes represent "states" that are traversed in order in the ECG.
Arrows represent transitions between time steps, which can result in remaining within a state, or making a transition to the next one. C. Example of CNN-HMM output for an
ECG. CNN-HMM based classes are shown below the image. The ST and T wave segments have been combined.
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demonstrated a strong correlation with those from MUSE
(ρ=0.77-0.98, Figure 3).
K. ecgAI Performance to Quantify Cardiac Structure.
Though it is not standard to quantify the severity of cardiac
structural abnormalities using ECGs, the presence of contin-
uous measurements in the gold-standard echocardiographic
studies enabled us to train ecgAI to estimate quantitative met-
rics. Median absolute deviation of ecgAI predictions against
reference echo measurements varied by structure: the lowest
deviation was for LVMi (16.5%), intermediate deviation was
for mitral annulus medial e’ (19.1%), and the greatest devia-
tion was for LAVOLi (22.9%) (Table 1). For all three struc-
tural measurements, there was a tendency to overestimate
low values and underestimate high values (Figures 4A, 4B
and S1), suggesting a more limited dynamic range for ECG
compared to echo. When the continuous measurements for
the cardiac structures were dichotomized, the model demon-
strated strong discrimination for both left ventricular hyper-
trophy and diastolic dysfunction with AUROCs of 0.87 (95%
confidence interval: 0.86-0.89) and 0.84 (95% CI 0.82-0.86)
respectively (Figure 4C, 4D). Left atrial enlargement had a
much lower AUROC of 0.62 (95% CI 0.60-0.64), most likely
reflecting a failure of the ECG to correctly estimate large
atrial volumes.
We identified those ECG components (waveform volt-
ages and intervals from the 725-component patient-level
ECG profile) which most strongly contributed to classifica-
tion for each cardiac structural abnormality (Figure 4E, F,
Table S11. For LVMi, QRS duration was the strongest pre-
dictor with a variable score of 4.0, followed by P wave dura-
tion (3.3), QT duration (1.7), the middle portion of the QRS
from lead V3 (1.5, segments 8-12 out of a total of 20) and
the middle portion of the ST-T complex from lead V1 (1.3,
segments 12-16) (Figure 4E, Table S11). Collectively, these
reflect many of the classic criteria for left ventricular hyper-
trophy (28).
For medial e’ the strongest predictors were PR duration
(3.1), QT duration (2.9), P wave duration (2.4), the middle
portion of the ST-T complex from lead V1 (1.8, segments
8-12), and heart rate (1.2). For LAVOLi, top predictors were
QT duration (4.6), P wave duration (4.5), QRS duration (1.4),
PR duration (1.3) and the middle portion of the QRS from
lead V6 (0.97).
L. ecgAI Performance for Cardiac Disease Detection.
In addition to quantifying cardiac structure, we applied ec-
gAI toward disease classification and the discovery of ECG
predictors of each disease. (Figure 5). The strongest dis-
crimination was observed for a model for PAH which had an
AUROC of 0.94 (95% CI 0.93-0.95). Key predictors for PAH
included the middle portion of QRS from lead V1 (variable
score = 4.5, segments 8-12), reflecting a tall R’ (Figure 5G,
p<2x10−16), followed by the latter and middle portions of the
QRS from lead V1 (1.6, segments 12-16; 1.4 segments 12-
16), reflecting a deep S wave; and the early portion of the P-
PR complex from lead V3 (0.9, segments 4-8) and aVR (0.9,
segments 4-8), presumably reflecting right atrial enlargement
(Figure 5A-5B, Table S12).
HCM had the next strongest discrimination with an AU-
ROC of 0.91 (95% CI 0.90-0.92). The strongest predictors of
HCM were the latter portion of the ST-T complex from lead
V1 (3.8, segments 12-16), which can be markedly deeper in
some HCM patients (Figure 5H, p<2x10−16), the P wave du-
ration (3.5), QT duration (2.7), PR duration (2.4), and the
middle portion of the QRS from lead aVR (1.3, segments 12-
16) (Figure 5C-5D, Table S12).
CA had an AUROC of 0.86 (95% CI 0.82-0.89), and the
strongest predictors in this model were the early portion of
the QRS from lead aVR (3.0, segments 4-8), which is blunted
in voltage in CA patients ((Figure 5I, p=3x10−7), QRS du-
ration (1.3), the middle and early portions of the QRS from
lead I (1.2, segments 8-12; 1.1, segments 4-8), and the ear-
liest portion of the QRS from lead V1 (1.1, segments 0-4)
(Figure 5E-5F, Table S12).
The MVP showed the weakest discrimination, with an
AUROC of 0.77 (95% CI 0.76-0.78, 5), a disease not known
to strongly impact ECG morphology. The top predictors for
MVP included PR duration (3.3), the early portion of the
QRS from lead V2 (1.2, segments 4-8), the earliest portion
of the QRS from lead V3 (1.2, segments 0-4), P wave dura-
tion (1.1) and QT duration (0.97) (Figure S2, Table S12).
M. Serial ECGs Analysis with ecgAI to Perform With-
in-Patient Disease Tracking. By applying ecgAI to serial
ECGs of PAH patients, we obtained a progression of scores
over time corresponding to the degree to which the model
estimated likelihood of PAH based on ECG features (Figure
6A). The dashed blue line represents the PAH score at which
PAH is identified with 80% sensitivity and 90% specificity.
Patients typically have scores that remain with a narrow range
but there are some exceptions - and we highlight the three
most prominent ones. Figure 6B shows a time course of ECG
tracings for the individual depicted by the purple trajectory
in Figure 6A). In 2010 and 2011, ECG tracings do not have
any marked abnormalities. In 2015 and 2017, ECG tracings
appear increasingly abnormal, with a prominent R wave and
T wave inversion in lead V1, and QRS changes and a tall
prominent P wave in lead I. These progressive ECG changes
over time correspond with the increasing PAH scores from
2010-2017.
Two other patients (trajectories colored in red and yel-
low) had precipitous decreases followed by subsequent in-
creases in score (Figure S3). In both cases, the ECG trac-
ings from the high PAH score year appear abnormal, featur-
ing prominent R waves in V1 and a more negatively directed
QRS vector in lead I. In contrast (and for unclear reasons),
the subsequent low PAH score ECG tracings for both indi-
viduals appear substantially different and more normal, with
a decrease in R wave prominence in V1 and normalization of
the QRS in lead I (Figure S3B). The GBM PAH score thus
tracks well with visible morphological change in the ECG.
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Metric Number of ECGs Used forComparison Median Value (IQR)
Absolute Deviation:
ecgAI vs. Reference
(as % of Reference)
50% 75% 95%
Heart Rate (beats/minute) 35466 73 (63–86) 0.6 1.5 9.8
PR Interval (ms) 35466 160 (144–180) 3.0 5.9 27.4
QRS Duration (ms) 35466 90 (82–100) 5.6 9.7 18.7
QT Interval (ms) 35466 402 (374–430) 4.4 6.3 23.6
Left ventricular mass index (g/m2) 8631 79.8 (66.2–97.3) 16.5 28.9 59.8
Mitral annulus e’ (cm/sec) 3629 0.071(0.056–0.090) 19.1 33.4 71.4
Left atrial volume index (mL/m2) 7053 26.9 (20.9–35.3) 22.9 41.2 99.1
Table 1. Comparison of ecgAI-derived measurements and those derived from MUSE (ECG inervals) or 2-dimensional echocardiography (structure/function
metrics). The absolute differences between ecgAI and reference values are reported as % of reference measurements in order to compare across metrics. For each metric,
50%, 75%, and 95% of studies have an absolute difference between automated and manual measurements that is less than the value included in the corresponding columns.
IQR = interquartile range.
Fig. 3. Comparison of ecgAI (HMM+CNN) derived measurements and MUSE/UCSF values for four commonly reported ECG measurements. Each scatterplot depicts
35,466 comparisons. The line y=x is drawn to help identify any bias. The unit for heart rate is beats per minute while that of the other three metrics is milliseconds.
Discussion
In keeping with a widespread adoption of machine learning
across nearly every industry, there has been a dramatic in-
crease in publications applying these methods to carry out
routine diagnostic tasks in medicine. Most of these have em-
phasized matching or even outperforming practicing physi-
cians, whether it be for interpreting retinograms (10), skin
disorders (11), chest x-rays (29), mammograms (30), bone
x-rays (31), heart rhythm abnormalities (20), or deciphering
which view was collected by a cardiac sonographer (32, 33).
As the field matures, it will be important to think carefully
about how exactly these automated interpretation models will
be accommodated within the current clinical workflow. Our
current work, similar to our prior work on echocardiography
(13), proposes how fully automated interpretation might en-
able studies that otherwise would not be done, such as detect-
ing and tracking adverse cardiac remodeling in asymptomatic
patients in a primary care clinic. Nonetheless, for all these
applications that hope to guide medical decisions, an impor-
tant question is whether the machine learning algorithms can
provide physicians and patients an adequate explanation as
to why a certain automated diagnosis or recommendation was
made (12). Although in some examples that may be unneces-
sary - and a black box approach might suffice - in most cases
where there is need of a complex decision, it is expected that
a clear rationale is provided, ideally one which can be ver-
ified (in our case, visually) by the physician and potentially
even by the patient.
Here we emphasize three facets of an artificial intelli-
gence approach to ECG interpretation that differs from these
prior works: 1) the use of machine learning to extend the
utility of a diagnostic tool to applications beyond what would
be possible by human readers; 2) the focus on eliciting inter-
pretable features which can be used to both justify an auto-
mated diagnosis within clinical care and inspire new research
on physiological correlates of disease; and 3) the demonstra-
tion of a flexible framework that permits estimation or clas-
sification for a broad range of cardiac metrics and diseases.
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Fig. 4. Estimating cardiac structure and function using patient-level ECG profiles. Bland-Altman plots comparing estimates of left ventricular mass index (A) and mitral
annulus medial e’ (B) values using ECG alone compared to echo-derived values. Number of studies depicted in comparison is shown. Orange, red, and blue dashed lines
delineate the central 50%, 75% and 95% of patients, as judged by difference between automated and manual measurements. The solid gray line indicates the median.
Receiver operating characteristic (ROC) curves for classification models for left ventricular hypertrophy (C) and diastolic dysfunction (D). The area under the ROC curve is
indicated. Variable importance for LVMi (E) and medial e’ (F) estimation models. The predictors most important for each model are highlighted with the relative importance
indicated by the shading (white to blue). Informative intervals are depicted below the plot while lead-specific segments of the ECG are highlighted on the voltage trace.
Although feature extraction has long been part of the typical
ECG analysis pipeline (34), it has been performed primarily
for the purpose of reducing the ECG to a simpler set of de-
scriptors, since it was not tractable to input raw ECG data
into classifier algorithms and yet maintain algorithm perfor-
mance. The recent emergence of deep neural networks for
ECG analysis (20, 35–37) arguably lessened both of these
needs, making it possible to input raw ECG data and demon-
strating performance gains for certain tasks. But neural net-
works, at least presently, are used at the cost of interpretabil-
ity. Feature extraction within our framework aims instead to
delineate portions of the ECG signal that have clinical mean-
ing and culminates in the patient-level ECG profile, enabling
the use of down-sampled raw data for machine learning. This
results in outputs that are more interpretable, even compared
to approaches where simple abstractions of the ECG signal,
such as slopes, ratios, or displacement, are performed (28).
While we apply this approach to three structural and four
disease entities, this framework can be expanded broadly to
any application, many of which may not be readily apparent.
Notably, the composition of the ECG feature vector could
also be modified in future applications to incorporate disease-
specific knowledge in order to better capture specific aspects
of cardiac physiology.
We believe that the enormous potential of applying ma-
chine learning to medicine must lie in its ability to illumi-
nate patterns across large quantities of data in a way that pre-
serves clinical interpretability, both to maintain physician and
patient agency in decision-making and to enable knowledge
discovery. And we suggest that this does not necessarily have
to come at the cost of algorithm performance. In the case of
ECG-disease correlates, there is ample evidence that previ-
ously recognized ECG-predictors represent only a fraction of
informative features of any disease (35, 38), making the case
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Fig. 5. Detecting disease using patient-level ECG profiles. ROC curves (with AUROC indicated) for disease detection models for PAH (A), HCM (C), CA (E), and MVP
(F). Corresponding variable importance plots (B, D, F, H) with coloring as in Figure 4. Violin plots indicating distribution of the top predictive feature in cases and controls for
PAH (G), HCM (H), and CA (I). All are significant at p<10−6.
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Fig. 6. ECG-profile based models can be used to track changes in patient ECGs in PAH. A. Scores for PAH detection for individual patients with measurements for 2
or more years. A median of all scores for each year is computed and lines are drawn connecting scores for different years for each patient. The blue dashed line indicates
a score threshold with 90% specificity and 80% sensitivity for a diagnosis of PAH. Purple, red and yellow lines highlight score trajectories for three patients with dramatic
variation in scores, crossing this threshold. B. Variation in ECG patterns for leads I and V1 from 2010-2017 for patient highlighted in purple in A. Over time, as the PAH score
increases, the QRS axis swings progressively rightward (lead I), the P wave height grows, and the R’ wave in lead V1 increases in size.
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for data-driven discovery of novel ECG correlates. Apply-
ing our analysis framework to detect several diseases demon-
strated strong discriminative ability to identify PAH (AU-
ROC=0.94) and HCM (AUROC=0.91), and slightly weaker
ability for CA (AUROC=0.86) and MVP (AUROC=0.77),
using ECG inputs alone. Because the ECG is only one com-
ponent upon which the clinical diagnosis for any of these dis-
eases is made, most prior studies tend to highlight the asso-
ciation of various ECG features with disease status, rather
than describing the global discrimination performance (39–
45) — limiting our ability to directly compare our perfor-
mance. In work bearing the most similarity to ours (41),
the authors used various ECG features to identify HCM pa-
tients from non-HCM patients, and also reported strong per-
formance across several global metrics for HCM detection.
The focus of their approach, however, remained the optimiza-
tion of predictive performance rather than enabling clinical
interpretability through informative ECG features. Similarly,
we emphasize the distinction between our approach and oth-
ers which use manually-derived features or proprietary soft-
ware, which significantly limits scalability and interpretabil-
ity (46). In our study, the ECG-based features identified as
most strongly contributing to prediction for each disease have
clear physiologic parallels — such as ECG-correlates of right
ventricular hypertrophy in PAH and myocardial infiltration in
CA — which conforms to our expectations based on patho-
physiology, and increases confidence in and acceptance of
model performance. Furthermore, the novel predictors iden-
tified by our models may provide inroads into future investi-
gation.
It has long been recognized that serial ECGs can reflect
changes in cardiac structure and morphology, which can also
correlate with risk for adverse outcomes (47). Prior efforts
have illustrated that ECG features change with disease pro-
gression (48, 49) and even in response to treatment (50). Our
approach is well suited to perform algorithmic longitudinal
ECG tracking, and has the advantage of not being limited to a
priori derived ECG features, and instead can learn high level
interactions or continuous feature weights from the data.
Although we used a specific machine learning pipeline
to rapidly segmenting ECG in this work, other methods, in-
cluding any of the existing heuristic based segmentation al-
gorithms, could also be used to derive patient-level ECG pro-
files (51). We also note as an additional limitation that our
models are currently optimized to analyze ECGs in normal
sinus rhythm. To obtain ECG profiles for patients with more
complex rhythms (such as the presence of premature or paced
beats) will require expanding our training data and the states
considered in our HMM, though we envisage these would
be straightforward to train within a CNN-HMM framework.
Furthermore, although large in scale, our data still derived
from a single medical center.
Quantitative patient tracking using the output of mul-
tidimensional models is not performed routinely for ECGs
or even echos, in part because of long-standing fears that it
might obscure the diagnostic process (52, 53). With the cur-
rent wide-spread availability of digital data, we strongly be-
lieve such concerns should be revisited, both for the benefit
of the physician and patient. To this end, a primary motiva-
tion of this work is to demonstrate how we can extract much
more knowledge from our current low-cost input data, all in
an automated manner, and yet remain transparent to physi-
cians, patients, and researchers about the provenance of these
insights.
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Supplementary Note 1: Convolutional Neural Networks for Segmentation
Our implementation for segmentation is based on the U-net architecture (18), illustrated in Figure 2, but novel in its adaptation
to 1-D feature vector inputs. The architecture consists of "Convolution Blocks N" ("CB N" for short), which are repeated
groups of 3 consecutive convolution layers that apply 1xN filters with the "same" padding. The network takes an input of
2000x12 images (12 leads each sampled to 2000 pixels) that is fed into two sets of contracting and expanding paths. The first
set of contracting and expanding paths consists of 7 convolution blocks that applies convolutions with filter sizes starting from
1x19 to 1x15 to 1x11. The contracting path is implemented by applying 2x2 max pool after the first 5 convolution blocks and
the expanding path is implemented by applying an 8x8 deconvolution layer and a 2x2 deconvolution layer after the next two
convolution blocks respectively. The intuition for this set of convolutions is to independently detect features between the 12
leads by having convolution filters that only slide along one lead at a time. A 12x1 convolution with valid padding is then
applied to collapse the 12 lead vectors into 1 feature vector. This feeds into the second set of contracting and expanding path,
which consists of a convolution block with 1x11 filters followed by a 2x2 max pool and a convolution block with 1x11 filters
followed by a 2x2 deconvolution layer. One more convolution block with 1x9 filters is applied before we create a 6 class
segmentation output. All deconvolution outputs in the expanding phase are concatenated with feature maps from convolution
block outputs in the contracting phase with the same image dimensions.
For stochastic optimization, we used the ADAM optimizer (54) with an initial learning rate of 1x10−5 and mini-batch size
of 5. For regularization, we applied a weight decay of 1x10−7 on all network weights and dropout with probability 0.5 on the
final convolution block. We ran our tests for 500 epochs, which takes 4 hours on a Nvidia GTX 1080. Accuracy was assessed
by 5-fold cross-validation.
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Fig. S1. Estimating left atrial volume index using patient-level ECG profiles. A. Bland-Altman plot comparing estimation of LAVOLi
values using ECG alone compared to echo-derived values. B. ROC curve for a binary classification of left atrial enlargement, as defined
by being in the upper 90th percentile of indexed left atrial volume. C. Variable importance as in Figure 4
All Patients Patients Used for Model
Characteristics Age (years ± sd) 58 ± 17 58 ± 17
Sex (% Female) 48 49
Left Ventricular Mass Index (g/m2) 85 ± 29 84 ± 26
Race (%) Unknown/Other 54 55
Non-Hispanic White 32 32
Black 6 6
Asian and Pacific Islander 6 6
Hispanic 1 1
Native American <1 <1
Year 2017 3550 (35) 3064 (35)
2016 3241 (32) 2732 (32)
2015 2356 (23) 2033 (24)
2014 935 (9) 802 (9)
Total 10082 8631
Table S1. Characteristics of Studies Used to Train Left Ventricular Mass Estimation Model
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Fig. S2. Detecting disease using patient-level ECG profiles. ROC curves (with AUROC indicated) for disease detection models for
MVP (A). Corresponding variable importance plots (B) with coloring as in Figure 4
All Patients Patients Used for Model
Characteristics Age (years ± sd) 59 ± 17 58 ± 17
Sex (% Female) 48 48
Left Atrial Volume Index (mL/m2) 30 ± 13 29 ± 12
Race (%) Unknown/Other 53 53
Non-Hispanic White 33 33
Black 7 6
Asian and Pacific Islander 6 6
Hispanic 1 1
Native American <1 <1
Year 2017 2888 (31) 2223 (32)
2016 2611 (35) 2431 (34)
2015 2084 (25) 1797 (25)
2014 706 (9) 602 (9)
Total 8289 7053
Table S2. Characteristics of Studies Used to Train Left Atrial Volume Estimation Model
All Patients Patients Used for Model
Characteristics Age (years ± sd) 59± 17 58 ± 17
Sex (% Female) 48 49
Mitral valve medial e’ (cm/s) 0.074 ± 0.026 0.074 ± 0.025
Race (%) Unknown/Other 53 53
Non-Hispanic White 34 34
Black 7 7
Asian and Pacific Islander 6 6
Hispanic 1 1
Native American <1 <1
Year 2017 963 (23) 847 (23)
2016 1674 (40) 1420 (39)
2015 1121 (27) 971 (27)
2014 447 (11) 391 (11)
Total 4205 3629
Table S3. Characteristics of Studies Used to Train Mitral Valve Annular e’ Estimation Model
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Fig. S3. ECG-profile based models can be used to track changes in patient ECGs in PAH. A. Scores for PAH detection for
individual patients with measurements for 2 or more years (repeat of Figure 6A). A median of all scores for each year is computed
and lines are drawn connecting scores for different years for each patient. The blue dashed line indicates a score threshold with 90%
specificity and 80% sensitivity for a diagnosis of PAH. Purple, red and yellow lines highlight score trajectories for three patients with
dramatic variation in scores, crossing this threshold. B. Variation in ECG patterns for leads I and V1 for patients highlighted in red
(B) and yellow (C) in A. In each case, ECGs show substantial temporal changes in complex morphology, particularly in those features
important for a PAH diagnosis (Figure 5)
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Cases Controls
Patients N (studies) 525 1764
Age (years ± sd) 52 ± 11 52 ± 11
Sex (% Female) 64 65
Race (%) Unknown/Other 49 47
Non-Hispanic White 44 45
Black 4 5
Asian and Pacific Islander 1 1
Hispanic 2 3
Year - Number of Studies (%) 2017 149 (28) 475 (27)
2016 194 (37) 639 (36)
2015 68 (13) 234 (13)
2014 52 (10) 192 (11)
2011 31 (6) 114 (6)
2010 31 (6) 110 (6)
Table S4. Characteristics of Studies Used to Train PAH Classification Model
Cases Controls
Patients N (studies) 706 2577
Age (years ± sd) 57 ± 15 58 ± 15
Sex (% Female) 47 46
Genotype Positive (%) 18 0
Race (%) Unknown/Other 44 41
Non-Hispanic White 44 47
Black 6 5
Asian and Pacific Islander 3 3
Hispanic 3 2
Year - Number of Studies (%) 2017 151 (21) 557 (22)
2016 160 (23) 557 (22)
2015 112 (16) 412 (16)
2014 133 (19) 475 (18)
2011 88 (12) 352 (13)
2010 62 (9) 224 (9)
Table S5. Characteristics of Studies Used to Train HCM Classification Model
Cases Controls
Patients N (studies) 180 636
Age (years) 67 ± 11 67 ± 11
Sex (% Female) 14 14
Race (%) Unknown/Other 26 26
Non-Hispanic White 49 50
Black 20 18
Asian and Pacific Islander 4 4
Hispanic <1 <1
Year - Number of Studies (%) 2017 32 (18) 122 (19)
2016 32 (18) 122 (19)
2015 33 (18) 124 (19)
2014 19 (11) 74 (12)
2011 34 (19) 108 (17)
2010 30 (13) 86 (14)
Table S6. Characteristics of Studies Used to Train Amyloid Classification Model
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Cases Controls
Patients N (studies) 1576 7493
Age (years ± sd) 61 ± 15 61 ± 15
Sex (% Female) 49 49
Race (%) Unknown/Other 36 36
Non-Hispanic White 56 57
Black 2 2
Asian and Pacific Islander 5 4
Hispanic <1 <1
Year - Number of Studies (%) 2017 307 (19) 979 (20)
2016 415 (26) 1302 (27)
2015 359 (23) 1050 (22)
2014 303 (19) 907 (19)
2011 80 (5) 269 (6)
2010 112 (7) 357 (7)
Table S7. Characteristics of Studies Used to Train MVP Classification Model
Cases Controls pvalue
Patients N (studies) 853 4272
Age (years ± sd) 62 ± 16 56 ± 17 9x10−22
Sex (% Female) 49 49
BMI (kg/m2, IQR) 29 (23-31) 27 (22-30) 1x10−5
LV Mass Index (g/m2, IQR) 139 (124-151) 65 (58-73) 0
Race (%) Unknown/Other 52 57
Non-Hispanic White 29 32
Black 13 4 3x10−18
Asian and Pacific Islander 6 6
Hispanic 1 1
Year - Number of Studies (%) 2017 304 (36) 1504 (35)
2016 272 (32) 1323 (31) 0.1
2015 170 (20) 1077 (25)
2014 109 (13) 368 (9)
Table S8. Characteristics of Studies Used to Train Left Ventricular Hypertrophy Classification Model
Cases Controls pvalue
Patients N (studies) 362 1823
Age (years ± sd) 69 ± 15 51 ± 16 5x10−74
Sex (% Female) 49 49
BMI (kg/m2, IQR) 27 (22-29) 27 (22-30) 0.49
MV annulus e’ (cm/s, IQR) 0.038 (0.034-0.042) 0.093 (0.079-0.104) 0
Race (%) Unknown/Other 52 54
Non-Hispanic White 32 35
Black 9 6 9x10−38
Asian and Pacific Islander 7 4
Hispanic 1 1
Year - Number of Studies (%) 2017 71 (20) 443 (24)
2016 138 (38) 717 (39) 7x10−7
2015 104 (29) 471 (26)
2014 49 (14) 192 (11)
Table S9. Characteristics of Studies Used to Train Diastolic Dysfunction Classification Model
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Cases Controls pvalue
Patients N (studies) 699 3490
Age (years ± sd) 66 ± 16 55 ± 17 6x10−53
Sex (% Female) 48 48
BMI (kg/m2, IQR) 28 (23-30) 28 (23-30) 0.41
Left atrial volume index (mL/m2, IQR) 55 (48-59) 20 (18-24) 0
Race (%) Unknown/Other 49 55
Non-Hispanic White 35 32
Black 10 6 0.03
Asian and Pacific Islander 5 6
Hispanic 1 1
Year - Number of Studies (%) 2017 263 (38) 1206 (986)
2016 241 (34) 991 (35) 0.1
2015 150 (21) 986 (28)
2014 45 (6) 307 (9)
Table S10. Characteristics of Studies Used to Train Left Atrial Enlargement Classification Model
Metric Variable Score
LV Mass Index QRS duration 4.0
P wave duration 3.3
QT duration 1.7
QRS V3 seg 8-12 1.5
ST-T v1 12-16 1.3
ST-T v1 8-12 1.2
QRS V3 seg 12-16 0.84
QRS aVL seg 12-16 0.84
QRS V6 seg 8-12 0.75
LA Volume Index QT duration 4.6
P wave duration 4.5
QRS duration 1.4
PR duration 1.3
QRS V6 seg 12-16 0.97
ST-T v1 8-12 0.88
QRS V3 seg 8-12 0.76
MV medial e’ PR duration 3.1
QT duration 2.9
P wave duration 2.4
ST-T V1 8-12 1.8
Heart rate 1.2
QRS aVF seg 8-12 1.1
QRS V6 seg 0-4 0.91
Table S11. Variable Importance for GBM Models for Cardiac Structure and Function
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Metric Variable Score
PAH QRS V1 seg 8-12 4.5
QRS V1 seg 12-16 1.6
QRS I seg 12-16 1.4
P-PR V3 seg 4-8 0.93
P-PR aVR seg 4-8 0.93
QRS I seg 8-12 0.91
QRS duration 0.87
QRS aVR seg 8-12 0.85
HCM ST-T V1 seg 12-16 3.8
P wave duration 3.5
QT duration 2.7
PR duration 2.4
QRS aVR seg 12-16 1.3
ST-T V1 seg 8-12 1.2
ST-T V5 seg 8-12 0.83
Heart rate 0.76
Amyloid QRS aVR seg 4-8 3.0
QRS duration 1.3
QRS I seg 8-12 1.2
QRS I seg 4-8 1.1
QRS V1 seg 0-4 1.1
QRS aVL seg 8-12 0.99
ST-T V2 seg 12-16 0.91
P wave duration 0.78
MVP PR duration 3.3
QRS V2 seg 4-8 1.2
QRS V3 seg 0-4 1.2
P wave duration 1.1
QT duration 0.97
P-PR V1 seg 0-4 0.75
Table S12. Variable Importance for GBM Models for Disease Detection
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